{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T17:02:10Z","timestamp":1748106130639},"reference-count":100,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Col. Bras. Cir."],"abstract":"<jats:p>ABSTRACT Cytoreductive surgery plus hypertermic intraperitoneal chemotherapy has emerged as a major comprehensive treatment of peritoneal malignancies and is currently the standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome as well as malignant peritoneal mesothelioma. Unfortunately, there are some worldwide variations of the cytoreductive surgery and hypertermic intraperitoneal chemotherapy techniques since no single technique has so far demonstrated its superiority over the others. Therefore, standardization of practices might enhance better comparisons between outcomes. In these settings, the Brazilian Society of Surgical Oncology considered it important to present a proposal for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil, with a special focus on producing homogeneous data for the developing Brazilian register for peritoneal surface malignancies.<\/jats:p>","DOI":"10.1590\/0100-69912017005016","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T23:36:03Z","timestamp":1507160163000},"page":"530-544","source":"Crossref","is-referenced-by-count":11,"title":["A proposal of Brazilian Society of Surgical Oncology (BSSO\/SBCO) for standardizing cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma"],"prefix":"10.1590","volume":"44","author":[{"given":"Thales Paulo","family":"Batista","sequence":"first","affiliation":[{"name":"Medicina Integral Professor Fernando Figueira Institute, Brazil; University of Pernambuco, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Jos\u00e9 Queiroz","family":"Sarmento","sequence":"additional","affiliation":[{"name":"Hospital de Base of the Federal District, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janina Ferreira","family":"Loureiro","sequence":"additional","affiliation":[{"name":"Complexo Hospitalar de Niter\u00f3i, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Petruzziello","sequence":"additional","affiliation":[{"name":"Marcelino Champagnat Hospital, Brazil; AC Camargo Cancer Center, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ademar","family":"Lopes","sequence":"additional","affiliation":[{"name":"AC Camargo Cancer Center, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassio Cortez","family":"Santos","sequence":"additional","affiliation":[{"name":"Hospital Geral de Fortaleza, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udio de Almeida","family":"Quadros","sequence":"additional","affiliation":[{"name":"S\u00e3o Rafael Hospital, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Hiroshi","family":"Akaishi","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Zanella","family":"Cordeiro","sequence":"additional","affiliation":[{"name":"Hospital de Caridade, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Jos\u00e9 Fern\u00e1ndez","family":"Coimbra","sequence":"additional","affiliation":[{"name":"AC Camargo Cancer Center, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Andreazza","family":"Laporte","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonaldson Santos","family":"Castro","sequence":"additional","affiliation":[{"name":"Complexo Hospitalar de Niter\u00f3i, Brazil; Nacional Cancer Institute, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranyell Matheus Spencer Sobreira","family":"Batista","sequence":"additional","affiliation":[{"name":"AC Camargo Cancer Center, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Aguiar J\u00fanior","sequence":"additional","affiliation":[{"name":"AC Camargo Cancer Center, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson Luiz","family":"Costa J\u00fanior","sequence":"additional","affiliation":[{"name":"AC Camargo Cancer Center, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio Oliveira","family":"Ferreira","sequence":"additional","affiliation":[{"name":"AC Camargo Cancer Center, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2017,10]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21277","article-title":"Looking up recent advances in understanding and treating peritoneal carcinomatosis","volume":"65","author":"Lambert LA","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jso.24248","article-title":"What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy a 25-year experience with 1,125 procedures","volume":"113","author":"Passot G","year":"2016","journal-title":"J Surg Oncol"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","article-title":"Intraperitoneal chemotherapy for peritoneal surface malignancy experience with 1,000 patients","volume":"218","author":"Levine EA","year":"2014","journal-title":"J Am Coll Surg"},{"issue":"20","key":"ref4","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua TC","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome","volume":"7","author":"Sugarbaker PH","year":"2006","journal-title":"Lancet Oncol"},{"issue":"36","key":"ref6","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma multi-institutional experience","volume":"27","author":"Yan TD","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma a systematic review and meta-analysis","volume":"22","author":"Helm JH","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Witkamp AJ","year":"2001","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/02656730701455318","article-title":"Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy","volume":"23","author":"Sugarbaker PH","year":"2007","journal-title":"Int J Hyperthermia"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/02656739709023545","article-title":"Reduction of cellular cisplatin resistance by hyperthermia - a review","volume":"13","author":"Hettinga JV","year":"1997","journal-title":"Int J Hyperthermia"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/onc.2015.82","article-title":"Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90","volume":"35","author":"Zunino B","year":"2016","journal-title":"Oncogene"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1245\/s10434-012-2784-6","article-title":"Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis role of heat shock proteins and dissecting effects of hyperthermia","volume":"20","author":"Pelz JO","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jso.23276","article-title":"HIPEC + EPIC versus HIPEC-alone differences in major complications following cytoreduction surgery for peritoneal malignancy","volume":"107","author":"McConnell YJ","year":"2013","journal-title":"J Surg Oncol"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.amjsurg.2015.03.008","article-title":"Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis","volume":"210","author":"Lam JY","year":"2015","journal-title":"Am J Surg"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1245\/s10434-015-4991-4","article-title":"Hyperthermic intraperitoneal chemotherapy after secondary cytoreduction in epithelial ovarian cancer a single-center comparative analysis","volume":"23","author":"Baiocchi G","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00268-008-9880-6","article-title":"Peritonectomy for peritoneal carcinomatosis long-term outcomes from a single Brazilian institution","volume":"33","author":"Akaishi E","year":"2009","journal-title":"World J Surg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1477-7819-10-195","article-title":"Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients","volume":"10","author":"Costa Jr WL","year":"2012","journal-title":"World J Surg Oncol"},{"issue":"Suppl 1","key":"ref18","first-page":"S199","article-title":"Anesthesia in patients undergoing cytoreductive surgery (CS) and intraoperative hyperthermic chemotherapy (HIPEC) [abstract] Eur J Surg","volume":"41","author":"Albuquerque TLC","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref19","first-page":"S201","article-title":"Morbidity and mortality of patients undergoing cytoreductive surgery and intraperitoneal chemotherapy (HIPEC) at S\u00e3o Rafael Hospital between 2011 and 2015 [abstract] Eur J Surg","volume":"41","author":"Velasquez ARE","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref20","first-page":"S199","article-title":"Malignant peritoneal mesothelioma a case report [abstract]. Eur J Surg","volume":"41","author":"Vieira HC","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref21","first-page":"S199","article-title":"A succesful case of HIPEC in a peritoneal mesothelioma patient [abstract] Eur J Surg","volume":"41","author":"Firmino NLJ","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref22","first-page":"S200","article-title":"Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of advanced ovarian cancer the first two cases of a pioneering clinical trial in Brazil [abstract]. Eur J Surg","volume":"41","author":"Oliveira DNA","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref23","first-page":"S200","article-title":"Cytoreductive surgery and HIPEC experience of the first patients operated in a public hospital [abstract]. Eur J Surg","volume":"41","author":"Reis TJCC","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref24","first-page":"S200","article-title":"Cytoreductive surgery and HIPEC for peritoneal metastasis by colon and appendix carcinoma [abstract] Eur J Surg","volume":"41","author":"Cordeiro EZ","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref25","first-page":"S201","article-title":"Economical feasibility of cytoreductive surgery and HIPEC by SUS [abstract] Eur J Surg","volume":"41","author":"Reis TJCC","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref26","first-page":"S201","article-title":"Intraperitoneal hyperthermic chemotherapy with high PCI and disease-free survival after 5 years a case report [abstract]. Eur J Surg","volume":"41","author":"Brito FPB","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref27","first-page":"S202","article-title":"Ovarian cancer with carcinomatosis a case report [abstract]. Eur J Surg","volume":"41","author":"Cereser Junior CH","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref28","first-page":"S202","article-title":"Positive impact of nutritional, anti-inflammatory and antihistamine therapy preoperatively in patients undergoing cytoreductive surgery and HIPEC [abstract] Eur J Surg","volume":"41","author":"Reis TJCC","year":"2015","journal-title":"Oncol"},{"issue":"Suppl 1","key":"ref29","first-page":"S203","article-title":"White-blood-cell count, lactate and C-reactive protein postoperative measures are associated with major complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [abstract] Eur J Surg","volume":"41","author":"Takahashi RM","year":"2015","journal-title":"Oncol"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1245\/s10434-016-5692-3","article-title":"Current delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS\/HIPEC) and perioperative practices an international survey of high-volume surgeons","volume":"24","author":"Maciver AH","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4251\/wjgo.v2.i1.31","article-title":"Selection of patients and staging of peritoneal surface malignancies","volume":"2","author":"Cotte E","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jso.21069","article-title":"Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy expert consensus statement","volume":"98","author":"Yan TD","year":"2008","journal-title":"J Surg Oncol"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2013.12.021","article-title":"Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei analysis of 519 patients","volume":"40","author":"Taflampas P","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.suronc.2016.09.002","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in elderly patients A systematic literature review","volume":"25","author":"L\u00f3pez-L\u00f3pez V","year":"2016","journal-title":"Surg Oncol"},{"issue":"Suppl 5","key":"ref35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1245\/s10434-016-5519-2","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly a case-controlled, multicenter study","volume":"23","author":"Alyami M","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A consensus for classification and pathologic reporting of Pseudomyxoma Peritonei and associated appendiceal neoplasia the results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process","volume":"40","author":"Carr NJ","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1245\/s10434-015-5047-5","article-title":"The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS\/HIPEC)","volume":"23","author":"Milovanov V","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain AN","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1742-6413.170726","article-title":"Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology","volume":"12","author":"Hjerpe A","year":"2015","journal-title":"Cytojournal"},{"issue":"9","key":"ref40","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cncr.25640","article-title":"A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database","volume":"117","author":"Yan TD","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/COC.0b013e3182a0e867","article-title":"Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma","volume":"38","author":"Pillai K","year":"2015","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","article-title":"The Role of Ki-67 and pre-cytoreduction parameters in selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)","volume":"23","author":"Kusamura S","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"ref43","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","article-title":"Diffuse malignant peritoneal mesothelioma long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"49","author":"Baratti D","year":"2013","journal-title":"Eur J Cancer"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jso.21060","article-title":"The eligibility for local-regional treatment of peritoneal surface malignancy","volume":"98","author":"Verwaal VJ","year":"2008","journal-title":"J Surg Oncol"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jso.21053","article-title":"Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination","volume":"98","author":"Esquivel J","year":"2008","journal-title":"J Surg Oncol"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker PH","year":"1995","journal-title":"Ann Surg"},{"issue":"2","key":"ref47","first-page":"54","article-title":"Cytoreductive surgery using peritonectomy and visceral resections for peritoneal surface malignancy","volume":"2","author":"Sugarbaker PH","year":"2013","journal-title":"Transl Gastrointest Cancer"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jso.21388","article-title":"Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies","volume":"100","author":"Deraco M","year":"2009","journal-title":"J Surg Oncol"},{"issue":"2","key":"ref49","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","author":"Spratt JS","year":"1980","journal-title":"Cancer Res"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.surg.2014.06.006","article-title":"High pressure does not counterbalance the advantages of open techniques over closed techniques during heated intraperitoneal chemotherapy with oxaliplatin","volume":"157","author":"Facy O","year":"2015","journal-title":"Surgery"},{"key":"ref51","first-page":"610597","article-title":"Peritoneal carcinomatosis intraoperative parameters in open (coliseum) versus closed abdomen HIPEC","volume":"2015","author":"Halkia E","year":"2015","journal-title":"Int J Surg Oncol"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12957-017-1119-2","article-title":"Are there intra-operative hemodynamic differences between the Coliseum and closed HIPEC techniques in the treatment of peritoneal metastasis A retrospective cohort study","volume":"15","author":"Rodr\u00edguez Silva C","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","article-title":"Best practice for perioperative management of patients with cytoreductive surgery and HIPEC","volume":"43","author":"Rasp\u00e9 C","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/02656736.2015.1007399","article-title":"Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma","volume":"31","author":"Rettenmaier MA","year":"2015","journal-title":"Int J Hyperthermia"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"S758","DOI":"10.1245\/s10434-015-4853-0","article-title":"A Temperature of 40 \u00b0C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC","volume":"22","author":"Schaaf L","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jso.21051","article-title":"Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy","volume":"98","author":"Kusamura S","year":"2008","journal-title":"J Surg Oncol"},{"issue":"4","key":"ref57","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jso.21061","article-title":"Hyperthermic intraperitoneal chemotherapy nomenclature and modalities of perfusion","volume":"98","author":"Glehen O","year":"2008","journal-title":"J Surg Oncol"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1590\/0100-69912016006014","article-title":"Exploring flow rate selection in HIPEC procedures","volume":"43","author":"Batista TP","year":"2016","journal-title":"Rev Col Bras Cir"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2014.12.025","article-title":"Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy","volume":"479","author":"Mehta AM","year":"2015","journal-title":"Int J Pharm"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1245\/s10434-016-5665-6","article-title":"Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution","volume":"24","author":"Mehta AM","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"ref61","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ejso.2014.03.013","article-title":"Contamination risk for operators performing semi-closed HIPEC procedure using cisplatin","volume":"40","author":"Caneparo A","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2486\/indhealth.2014-0025","article-title":"Evaluation of oxaliplatin exposure of healthcare workers during Heated Intraperitoneal Perioperative Chemotherapy (HIPEC)","volume":"53","author":"Villa AF","year":"2015","journal-title":"Ind Health"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jso.21740","article-title":"Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a Heated Intraperitoneal Perioperative Chemotherapy (HIPEC) procedure","volume":"103","author":"Konate A","year":"2011","journal-title":"J Surg Oncol"},{"issue":"2","key":"ref64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/000313481207800234","article-title":"Right hemicolectomy is not routinely indicated in pseudomyxoma peritonei","volume":"78","author":"Foster JM","year":"2012","journal-title":"Am Surg"},{"issue":"3","key":"ref65","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1245\/s10434-016-5632-2","article-title":"When and when not to perform a right colon resection with mucinous appendiceal neoplasms","volume":"24","author":"Sugarbaker PH","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"ref66","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jso.21058","article-title":"Technical aspects of cytoreductive surgery","volume":"98","author":"Kusamura S","year":"2008","journal-title":"J Surg Oncol"},{"issue":"5","key":"ref67","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1245\/s10434-012-2237-2","article-title":"Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma a controlled study","volume":"19","author":"Baratti D","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"ref68","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1245\/s10434-015-4961-x","article-title":"Avoiding diverting ileostomy in patients requiring complete pelvic peritonectomy","volume":"23","author":"Sugarbaker PH","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"ref69","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejso.2014.09.002","article-title":"Risk of definitive stoma after surgery for peritoneal malignancy in 958 patients comparative study between complete cytoreductive surgery and maximal tumor debulking","volume":"41","author":"Riss S","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1245\/s10434-013-3370-2","article-title":"Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC","volume":"21","author":"de Cuba EM","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"ref71","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11605-015-2743-1","article-title":"A randomized trial of goal directed vs standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"19","author":"Colantonio L","year":"2015","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"ref72","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.9738\/INTSURG-D-14-00138.1","article-title":"Hemodynamic monitoring during heated intraoperative intraperitoneal chemotherapy using the FloTrac\/Vigileo system","volume":"100","author":"Mavroudis C","year":"2015","journal-title":"Int Surg"},{"issue":"6","key":"ref73","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejso.2011.03.134","article-title":"Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer","volume":"37","author":"Cascales Campos PA","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"ref74","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.suronc.2016.08.001","article-title":"Effectiveness and failures of a fast track protocol after cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy in patients with peritoneal surface malignancies","volume":"25","author":"Cascales-Campos PA","year":"2016","journal-title":"Surg Oncol"},{"issue":"8","key":"ref75","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1245\/ASO.2003.01.018","article-title":"Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis morbidity and mortality analysis of 216 consecutive procedures","volume":"10","author":"Glehen O","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"ref76","first-page":"307317","article-title":"Intensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Is it necessary?","volume":"2014","author":"L\u00f3pez-Basave HN","year":"2014","journal-title":"J Oncol"},{"issue":"2","key":"ref77","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/sur.2016.102","article-title":"Infectious complications after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy","volume":"18","author":"Arslan NC","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"issue":"8","key":"ref78","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ejso.2013.10.015","article-title":"Postoperative infections after cytoreductive surgery and HIPEC for peritoneal carcinomatosis proposal and results from a prospective protocol study of prevention, surveillance and treatment","volume":"40","author":"Valle M","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"ref79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/0037-8682-0292-2014","article-title":"Evaluation of the predictive indices for candidemia in an adult intensive care unit","volume":"48","author":"Gaspar GG","year":"2015","journal-title":"Rev Soc Bras Med Trop"},{"issue":"5","key":"ref80","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7861\/clinmedicine.2-5-440","article-title":"Working Party of the Haematology\/Oncology Task Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen","volume":"2","author":"Davies JM","year":"2002","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"ref81","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajh.23930","article-title":"Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy A nationwide population-based study in France","volume":"90","author":"Moulis G","year":"2015","journal-title":"Am J Hematol"},{"issue":"6","key":"ref82","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1245\/s10434-016-5147-x","article-title":"Splenectomy increases postoperative complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"23","author":"Dagbert F","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"ref83","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jso.21057","article-title":"Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy","volume":"98","author":"Younan R","year":"2008","journal-title":"J Surg Oncol"},{"issue":"5","key":"ref84","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00268-015-3366-0","article-title":"Where Oncologic and Surgical Complication Scoring Systems Collide Time for a New Consensus for CRS\/HIPEC","volume":"40","author":"Lehmann K","year":"2016","journal-title":"World J Surg"},{"issue":"4","key":"ref85","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.21068","article-title":"The intraoperative staging systems in the management of peritoneal surface malignancy","volume":"98","author":"Portilla AG","year":"2008","journal-title":"J Surg Oncol"},{"issue":"4","key":"ref86","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.21072","article-title":"Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy","volume":"98","author":"Gonz\u00e1lez-Moreno S","year":"2008","journal-title":"J Surg Oncol"},{"issue":"4","key":"ref87","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/000313481408000415","article-title":"Comparison of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with mitomycin or carboplatin for diffuse malignant peritoneal mesothelioma","volume":"80","author":"Shetty SJ","year":"2014","journal-title":"Am Surg"},{"issue":"1","key":"ref88","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4251\/wjgo.v2.i1.36","article-title":"Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"2","author":"Baratti D","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"ref89","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4251\/wjgo.v2.i2.68","article-title":"Hyperthermic intraperitoneal chemotherapy Rationale and technique","volume":"2","author":"Gonz\u00e1lez-Moreno S","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"7","key":"ref90","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-016-5143-1","article-title":"Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy with oxaliplatin increases the risk of postoperative hemorrhagic complications analysis of predictive factors","volume":"23","author":"Charrier T","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"ref91","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jso.23728","article-title":"The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery","volume":"110","author":"Prada-Villaverde A","year":"2014","journal-title":"J Surg Oncol"},{"issue":"1","key":"ref92","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejso.2016.09.015","article-title":"Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis","volume":"43","author":"Leung V","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"ref93","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jso.23228","article-title":"Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis a matched-pair analysisTreatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis","volume":"107","author":"Glockzin G","year":"2013","journal-title":"J Surg Oncol"},{"issue":"2","key":"ref94","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","article-title":"Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis","volume":"254","author":"Quenet F","year":"2011","journal-title":"Ann Surg"},{"issue":"4","key":"ref95","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1245\/s10434-012-2845-x","article-title":"The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"20","author":"Deraco M","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","article-title":"Diffuse malignant peritoneal mesothelioma Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study","volume":"65","author":"Kepenekian V","year":"2016","journal-title":"Eur J Cancer"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1200\/EdBook_AM.2013.33.182","article-title":"Peritoneal mesothelioma the site of origin matters","author":"Kindler HL","year":"2013","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"5","key":"ref98","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1245\/s10434-015-4995-0","article-title":"Clinicopathologic and prognostic features in patients with peritoneal metastasis from mucinous adenocarcinoma, adenocarcinoma with signet ring cells, and adenocarcinoid of the appendix treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"23","author":"hemelandu C","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"ref99","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1245\/s10434-012-2789-1","article-title":"Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer","volume":"20","author":"Turner KM","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"ref100","first-page":"3","article-title":"Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"7","author":"Cummins KA","year":"2016","journal-title":"J Gastrointest Oncol"}],"container-title":["Revista do Col\u00e9gio Brasileiro de Cirurgi\u00f5es"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rcbc\/v44n5\/1809-4546-rcbc-44-05-00530.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T19:03:33Z","timestamp":1603047813000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-69912017000500530&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":100,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,10]]}},"alternative-id":["S0100-69912017000500530"],"URL":"https:\/\/doi.org\/10.1590\/0100-69912017005016","relation":{},"ISSN":["1809-4546","0100-6991"],"issn-type":[{"value":"1809-4546","type":"electronic"},{"value":"0100-6991","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}